Thermal Ablation Compared to Partial Hepatectomy for Recurrent Colorectal Liver Metastases: An Amsterdam Colorectal Liver Met Registry (AmCORE) Based Study
Abstract
:Simple Summary
Abstract
1. Introduction
2. Materials and Methods
2.1. Patient Selection
2.2. Repeat Local Treatment Procedures
2.3. Follow-Up
2.4. Data Collection and Statistical Analysis
3. Results
3.1. Patient Characteristics
3.2. Treatment Characteristics
3.3. Complications
3.4. Local Tumor Progression-Free Survival
3.5. Distant Progression-Free Survival
3.6. Overall Survival
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Abbreviations
18F-FDG | [18F]-fluoro-2-deoxy-D-glucose |
AmCORE | Amsterdam Colorectal Liver Met Registry |
ASA | American Society of Anesthesiologists score |
BMI | Body mass index |
COLLISION | Colorectal Liver Metastases: Surgery vs. Thermal Ablation |
Ce | Contrast-enhancement |
CI | Confidence interval |
CRC | Colorectal cancer |
CRLM | Colorectal liver metastases |
CT | Computed tomography |
CTCAE | Common Terminology Criteria for Adverse Events |
DPFS | Distant progression-free survival |
HR | Hazard ratio |
IRE | Irreversible electroporation |
IQR | Interquartile range |
LTP | Local tumor progression |
LTPFS | Local tumor progression-free survival |
MRI | Magnetic resonance imaging |
MWA | Microwave ablation |
OS | Overall survival |
PET | Positron emission tomography |
RCT | Randomized controlled trial |
RFA | Radiofrequency ablation |
SBRT | Stereotactic body radiation therapy |
SD | Standard deviation |
STROBE | Strengthening the Reporting of Observational studies in Epidemiology |
References
- WHO. Estimated Age-Standardized Incidence Rates (World) in 2020, All Cancers, both Sexes, All Ages. Available online: http://gco.iarc.fr/today/online-analysis-map (accessed on 4 March 2021).
- Engstrand, J.; Nilsson, H.; Stromberg, C.; Jonas, E.; Freedman, J. Colorectal cancer liver metastases—A population-based study on incidence, management and survival. BMC Cancer 2018, 18, 78. [Google Scholar] [CrossRef]
- Meijerink, M.R.; Puijk, R.S.; van Tilborg, A.; Henningsen, K.H.; Fernandez, L.G.; Neyt, M.; Heymans, J.; Frankema, J.S.; de Jong, K.P.; Richel, D.J.; et al. Radiofrequency and Microwave Ablation Compared to Systemic Chemotherapy and to Partial Hepatectomy in the Treatment of Colorectal Liver Metastases: A Systematic Review and Meta-Analysis. Cardiovasc. Interv. Radiol. 2018, 41, 1189–1204. [Google Scholar] [CrossRef] [Green Version]
- Hackl, C.; Neumann, P.; Gerken, M.; Loss, M.; Klinkhammer-Schalke, M.; Schlitt, H.J. Treatment of colorectal liver metastases in Germany: A ten-year population-based analysis of 5772 cases of primary colorectal adenocarcinoma. BMC Cancer 2014, 14. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gleisner, A.L.; Choti, M.A.; Assumpcao, L.; Nathan, H.; Schulick, R.D.; Pawlik, T.M. Colorectal liver metastases: Recurrence and survival following hepatic resection, radiofrequency ablation, and combined resection-radiofrequency ablation. Arch. Surg. 2008, 143, 1204–1212. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Abdalla, E.K.; Vauthey, J.N.; Ellis, L.M.; Ellis, V.; Pollock, R.; Broglio, K.R.; Hess, K.; Curley, S.A. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann. Surg. 2004, 239, 818–825. [Google Scholar] [CrossRef] [PubMed]
- Nieuwenhuizen, S.; Puijk, R.S.; van den Bemd, B.; Aldrighetti, L.; Arntz, M.; van den Boezem, P.B.; Bruynzeel, A.M.E.; Burgmans, M.C.; de Cobelli, F.; Coolsen, M.M.E.; et al. Resectability and Ablatability Criteria for the Treatment of Liver Only Colorectal Metastases: Multidisciplinary Consensus Document from the COLLISION Trial Group. Cancers 2020, 12, 1779. [Google Scholar] [CrossRef] [PubMed]
- Puijk, R.S.; Ruarus, A.H.; Vroomen, L.; van Tilborg, A.; Scheffer, H.J.; Nielsen, K.; de Jong, M.C.; de Vries, J.J.J.; Zonderhuis, B.M.; Eker, H.H.; et al. Colorectal liver metastases: Surgery versus thermal ablation (COLLISION)—A phase III single-blind prospective randomized controlled trial. BMC Cancer 2018, 18, 821. [Google Scholar] [CrossRef] [PubMed]
- Gillams, A.; Goldberg, N.; Ahmed, M.; Bale, R.; Breen, D.; Callstrom, M.; Chen, M.H.; Choi, B.I.; de Baere, T.; Dupuy, D.; et al. Thermal ablation of colorectal liver metastases: A position paper by an international panel of ablation experts, The Interventional Oncology Sans Frontieres meeting 2013. Eur. Radiol. 2015, 25, 3438–3454. [Google Scholar] [CrossRef]
- Vasiniotis Kamarinos, N.; Kaye, E.A.; Sofocleous, C.T. Image-Guided Thermal Ablation for Colorectal Liver Metastases. Tech. Vasc. Interv. Radiol. 2020, 23, 100672. [Google Scholar] [CrossRef]
- Tinguely, P.; Dal, G.; Bottai, M.; Nilsson, H.; Freedman, J.; Engstrand, J. Microwave ablation versus resection for colorectal cancer liver metastases—A propensity score analysis from a population-based nationwide registry. Eur. J. Surg. Oncol. 2020, 46, 476–485. [Google Scholar] [CrossRef]
- Weng, M.; Zhang, Y.; Zhou, D.; Yang, Y.; Tang, Z.; Zhao, M.; Quan, Z.; Gong, W. Radiofrequency ablation versus resection for colorectal cancer liver metastases: A meta-analysis. PLoS ONE 2012, 7, e45493. [Google Scholar] [CrossRef]
- Kron, P.; Linecker, M.; Jones, R.P.; Toogood, G.J.; Clavien, P.A.; Lodge, J.P.A. Ablation or Resection for Colorectal Liver Metastases? A Systematic Review of the Literature. Front. Oncol. 2019, 9, 1052. [Google Scholar] [CrossRef]
- Scherman, P.; Syk, I.; Holmberg, E.; Naredi, P.; Rizell, M. Impact of patient, primary tumor and metastatic pattern including tumor location on survival in patients undergoing ablation or resection for colorectal liver metastases: A population-based national cohort study. Eur. J. Surg. Oncol. 2020. [Google Scholar] [CrossRef]
- Saiura, A.; Yamamoto, J.; Hasegawa, K.; Koga, R.; Sakamoto, Y.; Hata, S.; Makuuchi, M.; Kokudo, N. Liver resection for multiple colorectal liver metastases with surgery up-front approach: Bi-institutional analysis of 736 consecutive cases. World J. Surg. 2012, 36, 2171–2178. [Google Scholar] [CrossRef] [PubMed]
- Viganò, L.; Pedicini, V.; Comito, T.; Carnaghi, C.; Costa, G.; Poretti, D.; Franzese, C.; Personeni, N.; Del Fabbro, D.; Rimassa, L.; et al. Aggressive and Multidisciplinary Local Approach to Iterative Recurrences of Colorectal Liver Metastases. World J. Surg. 2018, 42, 2651–2659. [Google Scholar] [CrossRef] [PubMed]
- Vigano, L.; Ferrero, A.; Lo Tesoriere, R.; Capussotti, L. Liver surgery for colorectal metastases: Results after 10 years of follow-up. Long-term survivors, late recurrences, and prognostic role of morbidity. Ann. Surg. Oncol. 2008, 15, 2458–2464. [Google Scholar] [CrossRef] [PubMed]
- de Jong, M.C.; Pulitano, C.; Ribero, D.; Strub, J.; Mentha, G.; Schulick, R.D.; Choti, M.A.; Aldrighetti, L.; Capussotti, L.; Pawlik, T.M. Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: An international multi-institutional analysis of 1669 patients. Ann. Surg. 2009, 250, 440–448. [Google Scholar] [CrossRef] [Green Version]
- de Jong, M.C.; Mayo, S.C.; Pulitano, C.; Lanella, S.; Ribero, D.; Strub, J.; Hubert, C.; Gigot, J.F.; Schulick, R.D.; Choti, M.A.; et al. Repeat curative intent liver surgery is safe and effective for recurrent colorectal liver metastasis: Results from an international multi-institutional analysis. J. Gastrointest. Surg. 2009, 13, 2141–2151. [Google Scholar] [CrossRef]
- Petrowsky, H.; Gonen, M.; Jarnagin, W.; Lorenz, M.; DeMatteo, R.; Heinrich, S.; Encke, A.; Blumgart, L.; Fong, Y. Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: A bi-institutional analysis. Ann. Surg. 2002, 235, 863–871. [Google Scholar] [CrossRef] [PubMed]
- Adam, R.; Bismuth, H.; Castaing, D.; Waechter, F.; Navarro, F.; Abascal, A.; Majno, P.; Engerran, L. Repeat hepatectomy for colorectal liver metastases. Ann. Surg. 1997, 225, 51–60. [Google Scholar] [CrossRef]
- Takamoto, T.; Hashimoto, T.; Miyata, A.; Shimada, K.; Maruyama, Y.; Makuuchi, M. Repeat Hepatectomy After Major Hepatectomy for Colorectal Liver Metastases. J. Gastrointest. Surg. 2020, 24, 380–387. [Google Scholar] [CrossRef]
- National Institute for Health and Care Excellence (N.I.C.E.). Treatment for Metastatic Colorectal Cancer in the Liver Amenable to Treatment with Curative Intent: Colorectal Cancer (Update): Evidence Review D2a. Available online: https://www.nice.org.uk/guidance/ng151/evidence/d2a-treatment-for-metastatic-colorectal-cancer-in-the-liver-amenable-to-treatment-with-curative-intent-pdf-253058083672 (accessed on 29 October 2020).
- National Institute for Health and Care Excellence (N.I.C.E.). Radiofrequency Ablation for Colorectal Liver Metastases. Available online: https://www.nice.org.uk/guidance/IPG327 (accessed on 29 October 2020).
- National Institute for Health and Care Excellence (N.I.C.E.). Microwave Ablation for Treating Liver Metastases. Available online: https://www.nice.org.uk/guidance/IPG553 (accessed on 29 October 2020).
- Hashiguchi, Y.; Muro, K.; Saito, Y.; Ito, Y.; Ajioka, Y.; Hamaguchi, T.; Hasegawa, K.; Hotta, K.; Ishida, H.; Ishiguro, M.; et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int. J. Clin. Oncol. 2019. [Google Scholar] [CrossRef] [Green Version]
- Integraal Kankercentrum Nederland (I.K.N.L.). Guideline Colorectaal Carcinoom. Available online: https://www.oncoline.nl/colorectaalcarcinoom (accessed on 29 October 2020).
- Dijkstra, M.; Nieuwenhuizen, S.; Puijk, R.S.; Geboers, B.; Timmer, F.E.F.; Schouten, E.A.C.; Scheffer, H.J.; de Vries, J.J.J.; Ket, J.C.F.; Versteeg, K.S.; et al. The Role of Neoadjuvant Chemotherapy in Repeat Local Treatment of Recurrent Colorectal Liver Metastases: A Systematic Review and Meta-Analysis. Cancers 2021, 13, 378. [Google Scholar] [CrossRef]
- Kabir, T.; Syn, N.; Goh, B.K.P. Current status of laparoscopic liver resection for the management of colorectal liver metastases. J. Gastrointest. Oncol. 2020, 11, 526–539. [Google Scholar] [CrossRef]
- Elias, D.; De Baere, T.; Smayra, T.; Ouellet, J.F.; Roche, A.; Lasser, P. Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumour recurrence after hepatectomy. Br. J. Surg. 2002, 89, 752–756. [Google Scholar] [CrossRef] [PubMed]
- von Elm, E.; Altman, D.G.; Egger, M.; Pocock, S.J.; Gotzsche, P.C.; Vandenbroucke, J.P.; Initiative, S. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. J. Clin. Epidemiol. 2008, 61, 344–349. [Google Scholar] [CrossRef] [Green Version]
- Crocetti, L.; de Baere, T.; Lencioni, R. Quality improvement guidelines for radiofrequency ablation of liver tumours. Cardiovasc. Intervent. Radiol. 2010, 33, 11–17. [Google Scholar] [CrossRef] [Green Version]
- Common Terminology Criteria for Adverse Events (CTCAE) v5.0. Available online: https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/CTCAE_v5_Quick_Reference_8.5x11.pdf (accessed on 25 November 2020).
- IBM Corp. Released 2019. IBM® SPSS® Statistics for Windows, Version 26.0; IBM Corp.: Armonk, NY, USA, 2019. [Google Scholar]
- R Core Team. R: A Language and Environment for Statistical Computing. R for Windows Version 4.0.3. R Foundation for Statistical Computing; R Core Team: Vienna, Austria, 2019. [Google Scholar]
- Froelich, M.F.; Schnitzer, M.L.; Rathmann, N.; Tollens, F.; Unterrainer, M.; Rennebaum, S.; Seidensticker, M.; Ricke, J.; Rubenthaler, J.; Kunz, W.G. Cost-Effectiveness Analysis of Local Ablation and Surgery for Liver Metastases of Oligometastatic Colorectal Cancer. Cancers 2021, 13, 1507. [Google Scholar] [CrossRef] [PubMed]
- Dupre, A.; Jones, R.P.; Diaz-Nieto, R.; Fenwick, S.W.; Poston, G.J.; Malik, H.Z. Curative-intent treatment of recurrent colorectal liver metastases: A comparison between ablation and resection. Eur. J. Surg. Oncol. 2017, 43, 1901–1907. [Google Scholar] [CrossRef]
- Sofocleous, C.T.; Petre, E.N.; Gonen, M.; Brown, K.T.; Solomon, S.B.; Covey, A.M.; Alago, W.; Brody, L.A.; Thornton, R.H.; D’Angelica, M.; et al. CT-guided radiofrequency ablation as a salvage treatment of colorectal cancer hepatic metastases developing after hepatectomy. J. Vasc. Interv. Radiol. 2011, 22, 755–761. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Fan, X.X.; Lv, S.Y.; Zhang, M.W.; Dai, X.Y.; Zhao, J.P.; Mao, D.F.; Zhang, Y. Clinical analysis of ultrasound-guided radiofrequency ablation for recurrent colorectal liver metastases after hepatectomy. World J. Surg. Oncol. 2020, 18, 76. [Google Scholar] [CrossRef]
- Hof, J.; Wertenbroek, M.W.; Peeters, P.M.; Widder, J.; Sieders, E.; de Jong, K.P. Outcomes after resection and/or radiofrequency ablation for recurrence after treatment of colorectal liver metastases. Br. J. Surg. 2016, 103, 1055–1062. [Google Scholar] [CrossRef]
- van Tilborg, A.A.; Scheffer, H.J.; van der Meijs, B.B.; van Werkum, M.H.; Melenhorst, M.C.; van den Tol, P.M.; Meijerink, M.R. Transcatheter CT hepatic arteriography-guided percutaneous ablation to treat ablation site recurrences of colorectal liver metastases: The incomplete ring sign. J. Vasc. Interv. Radiol. 2015, 26, 583–587.e581. [Google Scholar] [CrossRef]
- Puijk, R.S.; Ruarus, A.H.; Scheffer, H.J.; Vroomen, L.; van Tilborg, A.; de Vries, J.J.J.; Berger, F.H.; van den Tol, P.M.P.; Meijerink, M.R. Percutaneous Liver Tumour Ablation: Image Guidance, Endpoint Assessment, and Quality Control. Can. Assoc. Radiol. J. 2018, 69, 51–62. [Google Scholar] [CrossRef] [Green Version]
- Wang, X.; Sofocleous, C.T.; Erinjeri, J.P.; Petre, E.N.; Gonen, M.; Do, K.G.; Brown, K.T.; Covey, A.M.; Brody, L.A.; Alago, W.; et al. Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastases. Cardiovasc. Intervent. Radiol. 2013, 36, 166–175. [Google Scholar] [CrossRef] [Green Version]
- Shady, W.; Petre, E.N.; Do, K.G.; Gonen, M.; Yarmohammadi, H.; Brown, K.T.; Kemeny, N.E.; D’Angelica, M.; Kingham, P.T.; Solomon, S.B.; et al. Percutaneous Microwave versus Radiofrequency Ablation of Colorectal Liver Metastases: Ablation with Clear Margins (A0) Provides the Best Local Tumor Control. J. Vasc. Interv. Radiol. 2018, 29, 268–275. [Google Scholar] [CrossRef] [PubMed]
- Solbiati, M.; Muglia, R.; Goldberg, S.N.; Ierace, T.; Rotilio, A.; Passera, K.M.; Marre, I.; Solbiati, L. A novel software platform for volumetric assessment of ablation completeness. Int. J. Hyperth. 2019, 36, 337–343. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kaye, E.A.; Cornelis, F.H.; Petre, E.N.; Tyagi, N.; Shady, W.; Shi, W.; Zhang, Z.; Solomon, S.B.; Sofocleous, C.T.; Durack, J.C. Volumetric 3D assessment of ablation zones after thermal ablation of colorectal liver metastases to improve prediction of local tumor progression. Eur. Radiol. 2019, 29, 2698–2705. [Google Scholar] [CrossRef]
- Laimer, G.; Jaschke, N.; Schullian, P.; Putzer, D.; Eberle, G.; Solbiati, M.; Solbiati, L.; Goldberg, S.N.; Bale, R. Volumetric assessment of the periablational safety margin after thermal ablation of colorectal liver metastases. Eur. Radiol. 2021. [Google Scholar] [CrossRef] [PubMed]
- Fretland, A.A.; Dagenborg, V.J.; Bjornelv, G.M.W.; Kazaryan, A.M.; Kristiansen, R.; Fagerland, M.W.; Hausken, J.; Tonnessen, T.I.; Abildgaard, A.; Barkhatov, L.; et al. Laparoscopic Versus Open Resection for Colorectal Liver Metastases The OSLO-COMET Randomized Controlled Trial. Ann. Surg. 2018, 267, 199–207. [Google Scholar] [CrossRef] [Green Version]
Total | Repeat Thermal Ablation Group | Repeat Resection Group | p-Value | ||
---|---|---|---|---|---|
Number of patients | 136 | 100 (73.5) | 36 (26.5) | ||
Number of tumors | 224 | 170 (75.9) | 54 (24.1) | ||
Patient Characteristics | |||||
Gender | Male | 104 (76.5) | 79 (79.0) | 25 (69.4) | |
Female | 32 (23.5) | 21 (21.0) | 11 (30.6) | 0.259 a | |
Age (years) * | 66.0 (10.9) | 66.9 (11.4) | 63.3 (9.1) | 0.092 c | |
ASA physical status | 1 | 8 (5.9) | 7 (7.0) | 1 (2.8) | |
2 | 93 (68.4) | 67 (67.0) | 26 (72.2) | ||
3 | 35 (25.7) | 26 (26.0) | 9 (25.0) | 0.632 b | |
Comorbidities | None | 67 (49.3) | 47 (47.0) | 20 (55.6) | |
Minimal | 49 (36.0) | 38 (38.0) | 11 (30.6) | ||
Major | 20 (14.7) | 15 (15.0) | 5 (13.9) | 0.663 b | |
BMI (kg/cm2) * | 26.1 (4.2) | 26.4 (4.2) | 25.0 (4.0) | ||
Missing | 3 | 0 | 3 | 0.094 c | |
Primary tumor location | Rectum | 33 (24.3) | 22 (22.0) | 11 (30.6) | |
Colon left-sided | 67 (49.3) | 50 (50.0) | 17 (47.2) | ||
Colon right-sided | 36 (26.5) | 28 (28.0) | 8 (22.2) | 0.556 b | |
Characteristics Initial Local Treatment of CRLM | |||||
Initial CRLM diagnosis | Synchronous | 69 (51.9) | 51 (52.6) | 18 (50.0) | |
Metachronous | 64 (48.1) | 46 (47.4) | 18 (50.0) | 0.847 a | |
Missing | 3 | 3 | 0 | ||
Number of tumors | 1 | 38 (27.9) | 26 (26.0) | 12 (33.3) | |
2–5 | 65 (47.8) | 45 (45.0) | 20 (55.6) | ||
>5 | 33 (24.3) | 29 (29.0) | 4 (11.1) | 0.099 b | |
Size of largest metastasis (mm) | Small (1–30) | 75 (62.5) | 57 (61.3) | 18 (66.7) | |
Intermediate (31–50) | 36 (30.0) | 28 (30.1) | 8 (29.6) | ||
Large (>50) | 9 (7.5) | 8 (8.6) | 1 (3.7) | 0.681 b | |
Missing | 16 | 7 | 9 | ||
Extrahepatic disease | No | 111 (92.5) | 82 (93.2) | 29 (90.6) | |
Yes | 9 (7.5) | 6 (6.8) | 3 (9.4) | 0.699 a | |
Missing | 16 | 12 | 4 | ||
Type of procedure | Resection | 44 (32.4) | 27 (27.0) | 17 (47.2) | |
Thermal ablation | 43 (31.6) | 35 (35.0) | 8 (22.2) | ||
Resection and thermal ablation | 46 (33.8) | 37 (37.0) | 9 (25.0) | ||
IRE | 2 (1.5) | 1 (1.0) | 1 (2.8) | ||
SBRT | 1 (0.7) | 0 (0.0) | 1 (2.8) | 0.057 b | |
Characteristics Repeat Local Treatment of CRLM | |||||
Time between initial treatment and diagnosis recurrence (months) * | 6.9 (4.0–13.4) | 6.4 (4.0–10.4) | 12.2 (3.7–21.3) | 0.056 d | |
Number of tumors | 1 | 85 (62.5) | 59 (59.0) | 26 (72.2) | |
2–5 | 50 (36.8) | 40 (40.0) | 10 (27.8) | ||
>5 | 1 (0.7) | 1 (1.0) | 0 (0) | 0.337 b | |
Size of largest metastasis (mm) | Small (1–30) | 100 (84.7) | 80 (85.1) | 20 (83.3) | |
Intermediate (31–50) | 16 (13.6) | 13 (13.8) | 3 (12.5) | ||
Large (>50) | 2 (1.7) | 1 (1.1) | 1 (4.2) | 0.572 b | |
Missing | 18 | 6 | 12 | ||
Chemotherapy | No | 98 (72.1) | 71 (71.0) | 27 (75.0) | |
Yes | 38 (27.0) | 29 (29.0) | 9 (25.0) | 0.829 a |
Repeat Thermal Ablation Group n = 100 | Repeat Resection Group n = 36 | ||
---|---|---|---|
Type of repeat thermal ablation | RFA | 40 (40.0) | - |
Le VeenTM | 35 (35.0) | ||
Cool-tipTM | 4 (4.0) | ||
Others | 1 (1.0) | ||
MWA | 60 (60.0) | - | |
EmprintTM | 46 (46.0) | ||
Covidien EvidentTM | 5 (5.0) | ||
Others | 9 (9.0) | ||
Type of repeat resection | Minor (<3 segments) | - | 34 (97.1) |
Major (≥3 segments) | - | 1 (2.9) | |
Missing | 2 | ||
Approach | Open | 17 (17.2%) | 28 (84.8) |
Laparoscopic | 0 (0.0) | 5 (15.2) | |
Percutaneous | 82 (82.2%) | - | |
Missing | 1 | 3 |
Grade | Total | Repeat Thermal Ablation Group n = 100 | Repeat Resection Group n = 36 | p-Value |
---|---|---|---|---|
None | 97 (78.2) | 80 (80.8) | 17 (68.0) | 0.063 b |
Grade 1 | 8 (6.5) | 8 (8.1) | NR | |
Grade 2 | 8 (6.5) | 4 (4.0) | 4 (16.0) | |
Grade 3 | 9 (7.3) | 6 (6.1) | 3 (12.0) | |
Grade 4 | 2 (16) | 1 (1.0) | 1 (4.0) | |
Grade 5 | NR | NR | NR | |
Missing | 12 | 1 | 11 |
Univariable Analysis | Multivariable Analysis | ||||
---|---|---|---|---|---|
HR (CI) | p-Value | HR (CI) | p-Value | ||
Repeat local treatment | Repeat resection | Reference | 0.927 | Reference | 0.966 |
Repeat thermal ablation | 0.971 (0.515–1.831) | 0.986 (0.517–1.881) | |||
Patient-Related Factors | |||||
Gender | Male | Reference | 0.593 | ||
Female | 0.826 (0.409–1.668) | ||||
Age (years) | 1.027 (0.994–1.062) | 0.114 | |||
ASA physical status | 1 | Reference | 0.177 | ||
2 | 3.790 (0.894–16.078) | ||||
3 | 2.979 (0.644–13.780) | ||||
Comorbidities | None | Reference | 0.038 | Reference | 0.038 |
Minimal | 1.615 (0.853–3.061) | 1.618 (0.850–3.079) | |||
Major | 2.940 (1.264–6.838) | 2.936 (1.258–6.848) | |||
BMI (kg/cm2) | 0.978 (0.906–1.056) | 0.570 | |||
Primary tumor location | Rectum | Reference | 0.084 | Reference | 0.060 |
Colon left-sided | 0.902 (0.434–1.877) | 0.879 (0.421–1.835) | |||
Colon right-sided | 1.918 (0.862–4.268) | 2.002 (0.890–4.503) | |||
Factors Regarding Initial Local Treatment of CRLM | |||||
Initial CRLM diagnosis | Synchronous | Reference | 0.778 | ||
Metachronous | 0.917 (0.503–1.672) | ||||
Number of tumors | 1 | Reference | 0.618 | ||
2–5 | 0.906 (0.465–1.764) | ||||
>5 | 0.663 (0.287–1.535) | ||||
Size of largest metastasis (mm) | Small (1–30) | Reference | 0.349 | ||
Intermediate (31–50) | 0.864 (0.438–1.706) | ||||
Large (>50) | 0.333 (0.075–1.478) | ||||
Extrahepatic disease | No | Reference | 0.250 | ||
Yes | 0.311 (0.042–2.277) | ||||
Type of procedure | Resection | Reference | 0.798 | ||
Thermal ablation | 1.360 (0.669–2.765) | ||||
Resection andthermal ablation | 0.867 (0.413–1.822) | ||||
IRE | 1.128 (0.147–8.645) | ||||
SBRT | * | ||||
Factors regarding repeat local treatment of CRLM | |||||
Time between initial treatment and diagnosis recurrence (months) | 1.001 (0.980–1.022) | 0.943 | |||
Number of tumors | 1 | Reference | 0.620 | ||
2–5 | 1.350 (0.740–2.464) | ||||
>5 | * | ||||
Size of largest metastasis (mm) | Small (1–30) | Reference | 0.251 | ||
Intermediate (31–50) | 1.795 (0.812–3.971) | ||||
Large (>50) | 2.092 (0.481–9.103) | ||||
Chemotherapy | No | Reference | 0.825 | ||
Yes | 1.071 (0.582–1.970) |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Dijkstra, M.; Nieuwenhuizen, S.; Puijk, R.S.; Timmer, F.E.F.; Geboers, B.; Schouten, E.A.C.; Opperman, J.; Scheffer, H.J.; Vries, J.J.J.d.; Swijnenburg, R.-J.; et al. Thermal Ablation Compared to Partial Hepatectomy for Recurrent Colorectal Liver Metastases: An Amsterdam Colorectal Liver Met Registry (AmCORE) Based Study. Cancers 2021, 13, 2769. https://doi.org/10.3390/cancers13112769
Dijkstra M, Nieuwenhuizen S, Puijk RS, Timmer FEF, Geboers B, Schouten EAC, Opperman J, Scheffer HJ, Vries JJJd, Swijnenburg R-J, et al. Thermal Ablation Compared to Partial Hepatectomy for Recurrent Colorectal Liver Metastases: An Amsterdam Colorectal Liver Met Registry (AmCORE) Based Study. Cancers. 2021; 13(11):2769. https://doi.org/10.3390/cancers13112769
Chicago/Turabian StyleDijkstra, Madelon, Sanne Nieuwenhuizen, Robbert S. Puijk, Florentine E.F. Timmer, Bart Geboers, Evelien A.C. Schouten, Jip Opperman, Hester J. Scheffer, Jan J.J. de Vries, Rutger-Jan Swijnenburg, and et al. 2021. "Thermal Ablation Compared to Partial Hepatectomy for Recurrent Colorectal Liver Metastases: An Amsterdam Colorectal Liver Met Registry (AmCORE) Based Study" Cancers 13, no. 11: 2769. https://doi.org/10.3390/cancers13112769